From: Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis
logHOMA2-IR R2 | logHOMA2-%S R2 | logC-peptide R2 | |
---|---|---|---|
Base model | |||
Age, hypertension, BMI, TGL | 0.264 | 0.285 | 0.201 |
Base model + inflammation markers | |||
ESR | 0.270 | 0.293 | 0.250 |
CRP | 0.273 | 0.300 | 0.209 |
IL-6 | 0.266 | 0.292 | 0.196 |
Base model + RA activity parameters | |||
MMP3 | 0.299 | 0.330 | 0.199 |
DAS28-ESR | 0.315 | 0.336 | 0.235 |
DAS28-CRP | 0.321 | 0.342 | 0.219 |
DAS28-ESR ≥ 5.1 | 0.355 | 0.374 | 0.249 |
HAQ | 0.308 | 0.332 | 0.208 |
VAS | 0.325 | 0.343 | 0.217 |
TJC | 0.332 | 0.351 | 0.211 |
SJC | 0.280 | 0.300 | 0.202 |